Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity

Nadja Haiden; Francesco Cardona; Jens Schwindt; Angelika Berger; Stefan Kuhle; Monika Homoncik; Petra Jilma-Stohlawetz; Arnold Pollak; Bernd Jilma

doi:10.1160/TH04-02-0093

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 93(01): 118-123
DOI: 10.1160/TH04-02-0093

Platelets and Blood Cells

Schattauer GmbH

Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity

Nadja Haiden

¹Department of Pediatrics, Division of Neonatology and Intensive Care, University of Vienna, Austria

,

Francesco Cardona

²Department of Clinical Pharmacology, University of Vienna, Austria

,

Jens Schwindt

¹Department of Pediatrics, Division of Neonatology and Intensive Care, University of Vienna, Austria

,

Angelika Berger

¹Department of Pediatrics, Division of Neonatology and Intensive Care, University of Vienna, Austria

,

Stefan Kuhle

³Department of Neonatology, University Children's Hospital, Tübingen, Germany

,

Monika Homoncik

²Department of Clinical Pharmacology, University of Vienna, Austria

,

Petra Jilma-Stohlawetz

⁴Department of Blood Group Serology and Transfusion Medicine, University of Vienna, Austria

,

Arnold Pollak

¹Department of Pediatrics, Division of Neonatology and Intensive Care, University of Vienna, Austria

,

Bernd Jilma

²Department of Clinical Pharmacology, University of Vienna, Austria

› Author Affiliations

Abstract

Full Text

PDF Download

Keywords

Erythropoietin - platelet reactivity - VLBW infants - TRAP - TO+ platelets

References

References
1 Brown MS, Garcia JF, Phibbs RH. et al Decreased response of plasma immunoreactive erythropoietin to „available oxygen" in anemia of prematurity. J Pediatr 1984; 105: 793-8.
2 Shannon KM, Keith JF 3rd, Mentzer WC. et al Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995; 95: 1-8.
3 Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol 1995; 22: 641-55.
4 Sullivan JL. Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity. Am J Dis Child 1988; 142: 1341-4.
5 Strauss RG. Transfusion therapy in neonates. Am J Dis Child 1991; 145: 904-11.
6 Strauss RG, Burmeister LF, Johnson K. et al AS-1 red cells for neonatal transfusions: a randomized trial assessing donor exposure and safety. Transfusion 1996; 36: 873-8.
7 Ohls RK. Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity. Paediatr Drugs 2002; 4: 111-21.
8 Maier RF, Obladen M, Scigalla P. et al The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med 1994; 330: 1173-8.
9 Maier RF, Obladen M, Kattner E. et al High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr 1998; 132: 866-70.
10 Meyer MP, Meyer JH, Commerford A. et al Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo- controlled study. Pediatrics 1994; 93: 918-23.
11 Donato H, Vain N, Rendo P. et al Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics 2000; 105: 1066-72.
12 Pollak A, Hayde M, Hayn M. et al Effect of intravenous iron supplementation on erythropoiesis in erythropoietin- treated premature infants. Pediatrics 2001; 107: 78-85.
13 Al-Kharfy T, Smyth JA, Wadsworth L. et al Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr 1996; 129: 89-96.
14 Strauss RG. Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea. J Pediatr 1997; 131: 653-5.
15 Ohls RK, Ehrenkranz RA, Wright LL. et al Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics 2001; 108: 934-42.
16 Ohls RK, Harcum J, Schibler KR. et al The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr 1997; 131: 661-5.
17 Soubasi V, Kremenopoulos G, Diamanti E. et al Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr 1995; 127: 291-7.
18 Bader D, Blondheim O, Jonas R. et al Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity. Acta Paediatr 1996; 85: 496-501.
19 Wolf RF, Peng J, Friese P. et al Erythropoietin administration increases production and reactivity of platelets in dogs. Thromb Haemost 1997; 78: 1505-9.
20 Jilma-Stohlawetz P, Dzirlo L, Hergovich N. et al Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 2000; 95: 2983-9.
21 Rajasekhar D, Kestin AS, Bednarek FJ. et al Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994; 72: 957-63.
22 Rajasekhar D, Barnard MR, Bednarek FJ. et al Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 1997; 77: 1002-7.
23 Israels SJ, Cheang T, Roberston C. et al Impaired signal transduction in neonatal platelets. Pediatr Res 1999; 45: 687-91.
24 Pietrucha T, Wojciechowski T, Greger J. et al Differentiated reactivity of whole blood neonatal platelets to various agonists. Platelets 2001; 12: 99-107.
25 Worthington-White DA, Behnke M , Gross S. Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity. Am J Clin Nutr 1994; 60: 930-5.
26 Stohlawetz P, Folman CC, von dem Borne AE. et al Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost 1999; 81: 613-7.
27 Jilma-Stohlawetz P, Homoncik M, Jilma B. et al High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis. Br J Haematol 2001; 112: 466-8.
28 Cox D. Methods for monitoring platelet function. Am Heart J 1998; 135: S160-9.
29 Gatti L, Guarneri D, Caccamo ML. et al Platelet activation in newborns detected by flow-cytometry. Biol Neonate 1996; 70: 322-7.
30 Grosshaupt B, Muntean W , Sedlmayr P. Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur J Pediatr 1997; 156: 944-8.
31 Simak J, Holada K, Janota J. et al Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets. Pediatr Res 1999; 46: 445-9.
32 Homoncik M, Jilma B, Donham DC. et al Activation of calcium-dependent calmodulin by calcium( II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression. Blood Coagul Fibrinolysis 2003; 14: 131-8.
33 Hezard N, Potron G, Schlegel N. et al Unexpected persistence of platelet hyporeactivity beyond the neonatal period: a flow cytometric study in neonates, infants and older children. Thromb Haemost 2003; 90: 116-23.
34 Robinson M, Machin S, Mackie I. et al In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine. Br J Haematol 2000; 108: 859-64.
35 Joseph MA, Adams D, Maragos J. et al Flow cytometry of neonatal platelet RNA. J Pediatr Hematol Oncol 1996; 18: 277-81.
36 Peterec SM, Brennan SA, Rinder HM. et al Reticulated platelet values in normal and thrombocytopenic neonates. J Pediatr 1996; 129: 269-74.